Please assess the completion status of the following clinical trial:

Trial Title: Telmisartan in Haemodialysis Patients With Chronic Heart Failure

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Adult haemodialysis patients with CHF;~* New York Heart Association (NYHA) class II and III;~* Ejection fraction less or equal to 40% determined within 6 months; and~* Therapy with ACE inhibitors individually optimized and unchanged for 30 days before randomization~Exclusion Criteria:~* Hypotension during dialysis;~* Atrial fibrillation;~* Intolerant to low dose of telmisartan

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).